Expression of MUC5AC in Ocular Surface Epithelial Cells Using Cationized Gelatin Nanoparticles
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Decreased production of the mucin MUC5AC in the eye is related to several pathological conditions, including dry eye syndrome. A specific strategy for increasing the ocular levels of MUC5AC is not yet available. Using a plasmid specially designed to encode human MUC5AC, we evaluated the ability of hybrid cationized gelatin nanoparticles (NPs) containing polyanions (chondroitin sulfate or dextran sulfate) to transfect ocular epithelial cells. NPs were developed using the ionic gelation technique and characterized by a small size (<200 nm), positive zeta potential (+20/+30 mV), and high plasmid association efficiency (>95%). MUC5AC mRNA and protein were detected in conjunctival cells after in vitro transfection of the NPs. The in vivo administration of the NPs resulted in significantly higher MUC5AC expression in the conjunctiva compared to untreated control and naked plasmid. These results provide a proof-of-concept that these NPs are effective vehicles for gene therapy and candidates for restoring the MUC5AC concentration in the ocular surface.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Counterion-induced condensation of deoxyribonucleic acid. A light-scattering study
Wilson, R. W., & Bloomfield, V. A. (1979) · Biochemistry · doi:10.1021/bi00578a009 · Cited by 630
Cited by
Cationic polymers and their therapeutic potential
Samal, S. K., Dash, M., Van Vlierberghe, S., Kaplan, D. L., Chiellini, E., van Blitterswijk, C., Moroni, L., & Dubruel, P. (2012) · Chemical Society Reviews · doi:10.1039/c2cs35094g · Cited by 714
Gelatin-based nanoparticles as drug and gene delivery systems: Reviewing three decades of research
Elzoghby, A. O. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.09.019 · Cited by 651
Protein-Based Nanoparticles as Drug Delivery Systems
Hong, S., Choi, D. W., Kim, H. N., Park, C. G., Lee, W., & Park, H. H. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12070604 · Cited by 619
Gelatin carriers for drug and cell delivery in tissue engineering
Santoro, M., Tatara, A. M., & Mikos, A. G. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.014 · Cited by 395
Eco-Friendly Greener Synthesis of Nanoparticles
Bhardwaj, B., Singh, P., Kumar, A., Kumar, S., & Budhwar, V. (2020) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2020.067 · Cited by 274
Recent advancement of gelatin nanoparticles in drug and vaccine delivery
Sahoo, N., Sahoo, R. K., Biswas, N., Guha, A., & Kuotsu, K. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.08.006 · Cited by 270
Nanoparticle-based technologies for retinal gene therapy
Adijanto, J., & Naash, M. I. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.12.028 · Cited by 107
Cationic polymers and their self-assembly for antibacterial applications
Deka, S., Sharma, A., & Kumar, P. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150330110602 · Cited by 82
“Because of its biodegradability and biocompatibility, it is commonly employed for pharmaceutical and medical purposes [44-48].”
Background
Metadata
- Authors
- Konat Zorzi, G., Contreras-Ruiz, L., Párraga, J. E., López-García, A., Romero Bello, R., Diebold, Y., Seijo, B., & Sánchez, A.
- Venue
- Molecular Pharmaceutics
- Publisher
- American Chemical Society (ACS)
- Published
- 2011-08-02
- Volume
- 8
- Issue
- 5
- Pages
- 1783-1788
- ISSN
- 1543-8384 (ISSN-L)
- 1543-8392
- OpenAlex
- W1993340656
- Cited by
- 72
- References
- 1
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.